Cervarix, cjepivo protiv humanog papilomavirusa [tipova 16, 18] (rekombinantno, s adjuvansom, adsorbirano)
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
| Name | Cervarix, cjepivo protiv humanog papilomavirusa [tipova 16, 18] (rekombinantno, s adjuvansom, adsorbirano) |
|---|---|
| Active Substance | L1 protein humanog papilomavirusa tip 16 L1 protein humanog papilomavirusa tip 18 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| ATC Code | J07BM02 |
| Marketing status | nije stavljeno u promet |
| Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
| Link to the European Medicines Agency's (EMA) product information | download |
| Link to the European Commission's (EC) decisions | download |
